Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Marimed (MRMD) Interest & Investment Income (2018 - 2025)

Historic Interest & Investment Income for Marimed (MRMD) over the last 8 years, with Q3 2025 value amounting to $25000.0.

  • Marimed's Interest & Investment Income changed 0.0% to $25000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $112000.0, marking a year-over-year increase of 873.79%. This contributed to the annual value of $114000.0 for FY2024, which is 5777.78% down from last year.
  • According to the latest figures from Q3 2025, Marimed's Interest & Investment Income is $25000.0, which was down 0.0% from $25000.0 recorded in Q2 2025.
  • In the past 5 years, Marimed's Interest & Investment Income ranged from a high of $318000.0 in Q2 2022 and a low of $13000.0 during Q4 2021
  • In the last 5 years, Marimed's Interest & Investment Income had a median value of $29000.0 in 2023 and averaged $80315.8.
  • Its Interest & Investment Income has fluctuated over the past 5 years, first skyrocketed by 173846.15% in 2022, then plummeted by 8870.29% in 2023.
  • Marimed's Interest & Investment Income (Quarter) stood at $13000.0 in 2021, then skyrocketed by 1738.46% to $239000.0 in 2022, then tumbled by 88.7% to $27000.0 in 2023, then soared by 40.74% to $38000.0 in 2024, then plummeted by 34.21% to $25000.0 in 2025.
  • Its Interest & Investment Income stands at $25000.0 for Q3 2025, versus $25000.0 for Q2 2025 and $24000.0 for Q1 2025.